Literature DB >> 16560303

Utilization of Nicotinic Acid and Related Pyridine Compounds by the Proteus Group of Organisms.

M J Pelczar1, J R Porter.   

Abstract

Entities:  

Year:  1940        PMID: 16560303      PMCID: PMC374584          DOI: 10.1128/jb.39.4.429-435.1940

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  5 in total

1.  Nicotinic Acid and Thiamin Hydrochloride as Growth-promoting Factors for Brucella.

Authors:  G P Kerby
Journal:  J Bacteriol       Date:  1939-05       Impact factor: 3.490

2.  Nicotinic Acid as a Growth Accessory Substance for the Diphtheria Bacillus.

Authors:  J H Mueller
Journal:  J Bacteriol       Date:  1937-10       Impact factor: 3.490

3.  The specificity of aneurin and nicotinamide in the growth of Staph. aureus.

Authors:  B C Knight; H McIlwain
Journal:  Biochem J       Date:  1938-07       Impact factor: 3.857

4.  The nutrition of Staphylococcus aureus. The activities of nicotinamide, aneurin (vitamin B(1)) and related compounds.

Authors:  B C Knight
Journal:  Biochem J       Date:  1937-06       Impact factor: 3.857

5.  The nutrition of Staphylococcus aureus; nicotinic acid and vitamin B(1).

Authors:  B C Knight
Journal:  Biochem J       Date:  1937-05       Impact factor: 3.857

  5 in total
  4 in total

1.  The flavobacteria. II. Utilization of nitrogen compounds.

Authors:  H N PRINCE; R C CLEVERDON
Journal:  J Bacteriol       Date:  1955-03       Impact factor: 3.490

2.  RELATION OF BACTERIA TO VITAMINS AND OTHER GROWTH FACTORS.

Authors:  W H Peterson; M S Peterson
Journal:  Bacteriol Rev       Date:  1945-06

3.  Studies on nicotinamide derivatives.

Authors:  L COTE; J J OLESON
Journal:  J Bacteriol       Date:  1951-04       Impact factor: 3.490

4.  MIXED-CULTURE INTERACTIONS. I. COMMENSALISM OF PROTEUS VULGARIS WITH SACCHAROMYCES CEREVISIAE IN CONTINUOUS CULTURE.

Authors:  A SHINDALA; H R BUNGAY; N R KRIEG; K CULBERT
Journal:  J Bacteriol       Date:  1965-03       Impact factor: 3.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.